Gilead Sciences Exec Says Raising Full Year HIV Growth Expectations To 9%-10% YoY From Prior Guidance Of 8% Growth; Launch Preparations Full
Conference Call
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.